Skip to main content

gsk-glaxo-vert-logo

Novartis India has agreed to transfer its over-the-counter division (OTC Division) to GlaxoSmithKline Consumer (GSK CPL), a consumer healthcare joint venture (JV) between Swiss pharmaceutical firm Novartis and GSK, for about INR1.097bn ($17.6m)

{iframe}http://otc.pharmaceutical-business-review.com/news/novartis-to-sell-otc-business-to-gsk-consumer-for-176m-140115-4488641{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.